|
|
|||
|
||||
OverviewTimothy Gaginella and Antonio Guglietta bring together hands-on experts to critically review the many promising new areas of gastrointestinal pharmacology at the molecular level. Key chapters discuss such major themes as cyclooxygenase-2 inhibitors, the complexities of nitric oxide pathways in the gut, and the influence of cytokines on inflammatory bowel disease, as well as new opportunities for pharmacotherapy, including peptide growth factors, achykinins-particularly substance P and neurokinins-cholecystokinin receptors, and serotonin. Also examined as possible sites for treating motility disorders and visceral pain are the opioid receptors residing in the gut, and the H3-receptor agonists for treating gut inflammation and pain. Drug Development: Molecular Targets for Gastrointestinal Disease provides a comprehensive review of today's molecular pharmacological approaches to the discovery and development of novel drugs for gastrointestinal and liver diseases. Full Product DetailsAuthor: Timothy S. Gaginella , Antonio GugliettaPublisher: Humana Press Inc. Imprint: Humana Press Inc. Edition: Softcover reprint of hardcover 1st ed. 2000 Dimensions: Width: 15.20cm , Height: 1.60cm , Length: 22.90cm Weight: 0.430kg ISBN: 9781617370878ISBN 10: 1617370878 Pages: 278 Publication Date: 05 November 2010 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1 The Arachidonic Acid Pathway: New Molecules and Enzymes.- 2 Therapeutic Implications of the Nitric Oxide Pathway in Gastrointestinal Diseases.- 3 Cytokines: Opportunities for Therapeutic Intervention.- 4 Peptide Growth Factors in Gastrointestinal Disorder Therapeutics.- 5 Tachykinins: From Basic Concepts to Therapeutic Implications.- 6 CCKA Receptors in Gastrointestinal Disorders: New Therapeutic Implications.- 7 5-HT3/5-HT4 Receptors in Motility Disorders: New Therapeutic Agents.- 8 Opioid Receptors: Targets for New Gastrointestinal Drug Development.- 9 The Histamine H3 Receptor: Pharmacotherapy Targets in Gastrointestinal Disorders.ReviewsThe book focuses on specific molecules and the drugs that act on them, their receptors, metabolism or synthesis... a useful text for investigators of GI function and for pharmacologists interested in therapeutic compounds, their actions and targets. -Trends in Pharmaceutical Sciences Author InformationTab Content 6Author Website:Countries AvailableAll regions |